kapita selekta onkologi tht

Upload: putri-dwi-kartini

Post on 10-Feb-2018

246 views

Category:

Documents


1 download

TRANSCRIPT

  • 7/22/2019 Kapita Selekta Onkologi THT

    1/46

    ONKOLOGI

  • 7/22/2019 Kapita Selekta Onkologi THT

    2/46

    Incidence of primary Cancer in IndonesiaPathology Base 1990

    Rank organ % N

    1

    2

    3

    4

    5

    6

    7

    89

    10

    11

    Uterine Cervix

    Breast

    Skin

    Nasopharynx

    Ovary

    Lymphatic gland

    Rectum

    UnknownThyroid

    Soft tissue

    Colon

    19,18

    11,52

    8,64

    6,23

    4,95

    4,74

    4,62

    4,413,26

    2,75

    2,72

    3.817

    2.293

    1.719

    1.240

    985

    944

    920

    878649

    548

    542

    Total General 100,00 19.898

  • 7/22/2019 Kapita Selekta Onkologi THT

    3/46

    Malignancy in the Head & Neck

    Dept. OtorhinoLaryngology University of Indonesia

    Site of

    Malignancy

    Number of case%

    1980-1984

    Number of case %

    1988-1992

    1. Nasopharynx

    2. Sinonasal

    3. Larynx

    4. Oral cavity

    5. Oropharynx6. Neck & Others

    7. Ear

    8. Oesophagus

    9. Parotid gland

    57,59

    13,87

    12,83

    4,72

    4,722,09

    1.83

    1,83

    0,52

    71,77

    10,11

    9,97

    1,40

    1,691,12

    2,11

    1,54

    0,28

  • 7/22/2019 Kapita Selekta Onkologi THT

    4/46

    Prevalence/ Incidence

    Southern part of China : 30-50 case/100.000 population Indonesia (Native) : 4,7 Malaysia Malay : 1,1 Malaysia Chinese : 40,1 / 14,9 Singaporean Cantonese : 18,2 / 7,5 Singaporean Hokkien : 12,3 / 3,7

    Singaporean Malay : 4,3 / 1,5 Thailand(Chiang mai) : 4,1 / 1,6 Hong Kong : 28,5 / 11,2

  • 7/22/2019 Kapita Selekta Onkologi THT

    5/46

    Etiologi

    UtamaVirus Epstein-barr

    Faktor lain

    Rasmongoloid

    Cina,Hongkong,Vietnam,Taiwan,Thailand,Malaysia,SPore,Indonesia

    Genetik

    Dietmakanan yg diawetkan

    Eskimofrek.tinggi

    Ikan AsinHongkong,Cina selatan

    dll.Sex,sosial-budaya,higiene,infeksi

  • 7/22/2019 Kapita Selekta Onkologi THT

    6/46

    Genetik was detected by HLAdifferent part among :

    Chinese : A2-CW11-BW46-DR9AW33-C3-BW58-DR3

    Malaysian : A2&A9-B17&18-BW35 Indonesia :A2-A11-B18-BW6-CW(-)

    A11-A24-B13-B35-BW4,BW6,CW(-)

    Others country in Asia

  • 7/22/2019 Kapita Selekta Onkologi THT

    7/46

    Gejala KNF

    Gejala dinigejala Telinga

    gejala Hidung Gejala Lanjutgejala leher

    gejala paresis saraf

    kranial

  • 7/22/2019 Kapita Selekta Onkologi THT

    8/46

    Gejala mata (KNF)

  • 7/22/2019 Kapita Selekta Onkologi THT

    9/46

    Knfmetastasis ke kgb leher (N)

  • 7/22/2019 Kapita Selekta Onkologi THT

    10/46

    Gejala dini knf

    Gejala Telingatinnitus, rasa penuh,OME

    tuli konduktif unilateral

    Gejala hidungtersumbat,epistaksis

    riak berdarah

  • 7/22/2019 Kapita Selekta Onkologi THT

    11/46

    Gejala Lanjut knf

    Leherpembesaran kgb leher

    Paresis saraf kranialdiplopia,ptosis,baal di wajah

    Gejala metastasis jauhnyeri di tl.belakang,batuk

    darah

  • 7/22/2019 Kapita Selekta Onkologi THT

    12/46

    Deteksi dini&Anjuran pemeriksaan

    CT Scanhrs utk tumorkepala &leher

    Tumor marker/serologiIgA EBV anti VCAIgA EBV anti EA

    IgG EBV anti EA

    dpt di Labcheck up/mass screening

    Biopsidokter THT

    Akurat : Endoskopi

  • 7/22/2019 Kapita Selekta Onkologi THT

    13/46

    Level Kgb Leher

  • 7/22/2019 Kapita Selekta Onkologi THT

    14/46

    Serology EBV

    Serology Jakarta

    Singapore

    Hongkong

    IgA antiVCA

    Sensitivity 73,33

    95,00%

    80-90% 93,00%

  • 7/22/2019 Kapita Selekta Onkologi THT

    15/46

    Histopathology

    Type

    (WHO)

    Jakarta

    %

    Malaysia

    %

    Hong kong

    %

    I

    2

    3

    12,25

    5,22

    82,53

    35

    15

    50

    2,7

    6,9

    90,4

  • 7/22/2019 Kapita Selekta Onkologi THT

    16/46

    Treatment

    Radiasi Kemoradiasi(sensitisizer)

    Ajuvan/neoajuvan kemoterapi Pembedahan

  • 7/22/2019 Kapita Selekta Onkologi THT

    17/46

    Prognosis(li et al in Guang Zhou,1983/radiotherapy alone)

    5 years survival rate

    Stage I : 79,6%

    Stage II : 56,0%

    Stage III : 38,4%

    Stage IV : 16,4%

  • 7/22/2019 Kapita Selekta Onkologi THT

    18/46

    Pencegahan

    Vaksinasi(vaksin virus EBV) Screening massserologis,nasofaringoskopi Migrasi penduduk

    Peningkatan status sosial ekonomi Pendidikan kes.masyarakat Kampanye melalui media massa

    Peningkatan higiene Perlindungan pekerjaan obat2an

  • 7/22/2019 Kapita Selekta Onkologi THT

    19/46

    Karsinoma Sinonasal

    Epidemiologi

    Terbanyak ke 2 dr seluruh keganasan THT(10%) 1% dr keganasan seluruh tubuh Tertinggi di Jepang2/100.000 pddk/thn

    := 2 : 1 Tersering pada usia > 40thn

  • 7/22/2019 Kapita Selekta Onkologi THT

    20/46

    Karsinoma SinonasalEtiologi

    Belum diketahui Diduga akibat iritasi bahan Industri/kimia

    Nikel, debu/serbuk kayu,kulit,formalinKromium, terpentin dsb.

    Patut dicurigaiinfeksi kronis/berulang

    di sinonasal.

  • 7/22/2019 Kapita Selekta Onkologi THT

    21/46

    Gejala keganasan di Sinonasal (1)

    Gejala Hidung-Obstruksi & Rinore campurdarah (spt

    Epistaksis)-Ingus berbau krn terdapatJaringan nekrotik

    Gejala Mata-Diplopia

    -Proptosis-Optalmoplegia-Epifora-Gangguan Visus

  • 7/22/2019 Kapita Selekta Onkologi THT

    22/46

    Gejala Keganasan Sinonasal

    Gejala Rongga mulutpenonjolan Palatum

    durum

    gigi goyahgigi palsu tak pas lagi

  • 7/22/2019 Kapita Selekta Onkologi THT

    23/46

    Gejala Karsinoma Sinonasal (2)

    Gejala Wajah-deformitas pipi/ hidung

    /gigi akibat

    desakan/infitrasi tumor. Gejala Intrakranial

    -sakit kepala hebat

    -gangguan visus

    -kebocoran Likuor

  • 7/22/2019 Kapita Selekta Onkologi THT

    24/46

    Pemeriksaan keganasan Sinonasal

    Tampak massa tumor dirongga hidung

    CT Scan

    perluasantumor

  • 7/22/2019 Kapita Selekta Onkologi THT

    25/46

    Diteksi dini keganasan Sinonasal

    Sulit dilakukan Diketahui stlh tumor meluas deformitas wajah D/ dinibiopsirinitis/sinusitis Operasi Sinusitispem. PA

  • 7/22/2019 Kapita Selekta Onkologi THT

    26/46

    Treatment

    Surgery Radiotherapy Combination of its Chemotherapy : - Adjuvant

    - In distant metastasisNot suitable for surgery :

    Old age

    Poor general condition

    Refusal

    Massive local disease

    Involvement of skull base

  • 7/22/2019 Kapita Selekta Onkologi THT

    27/46

    Surgery

    Maksilektomi :-Partial- Total/radikal dgn/tanpa

    eksentrasi orbita

  • 7/22/2019 Kapita Selekta Onkologi THT

    28/46

    Tumor ganas Laring

    Di Sub.dept.Onkologi THTNomor 3 Di Amerika & EropaKeganasan No.1

    Data WHO

    35 Negara : 1,2/100.000/tahunEtiologi ?

    Perokok & Alkoholik

    - Risiko tinggi

    - : = 11 : 1

    - Usia > 60 thn.

  • 7/22/2019 Kapita Selekta Onkologi THT

    29/46

    Laryngeal Cancer

    Mostly- Squamous Cell Carcinoma

    - 10% of Head & Neck Cancer

    (Indonesia)

    - 1% of all cancer in Men (Western country)

    - Men : Women = 5 : 1

    - over 7 th decade

    Predisposing factorsSmoking & Alcohol

  • 7/22/2019 Kapita Selekta Onkologi THT

    30/46

    Incidence Cancer of Larynx

    per 100.000 Population/year

  • 7/22/2019 Kapita Selekta Onkologi THT

    31/46

    Laryngeal Cancer

    (primary tumor)

    Suplraglottic Gottic

    Subglottic

  • 7/22/2019 Kapita Selekta Onkologi THT

    32/46

    Gejala dini karsinoma Laring

    Suara serak terutama Glotiktergantung lokasi awal Tumor primer(T),

    dpt merpk gejala lanjut.

    Sesak nafas (Sub dan Supraglotik) Rasa tak nyaman(disfagia)/Nyeri(odinofagi)/

    gangguan proses menelan.

    Gejala lanjutbatuk2,sesak,stridor,hemoptisis.

  • 7/22/2019 Kapita Selekta Onkologi THT

    33/46

    Pemeriksaan Karsinoma Laring

    CT Scan Endoskopi/Laringoskopi

    langsung

    -menilai tumor primer :Lokasi & perluasan

    -ada/tidaknya paresis pitasuara

    -melalui monitor(pasien dptmelihat sendiri)

    -Biopsi laring

    Mikroskop(microlaryngoscopy)

  • 7/22/2019 Kapita Selekta Onkologi THT

    34/46

    Treatment

    (laryngeal cancer)

    1. Currative - surgery- Radiotherapy

    - or combination two modalitiesGlottic tumor T1 & T2 : Radiotherapy

    Small one vocal cord : Cordectomy

    T3 : Radiotherapy + surgery

    T4 dgn N : Total Laryngectomy + RND

  • 7/22/2019 Kapita Selekta Onkologi THT

    35/46

    Laryngectomy

  • 7/22/2019 Kapita Selekta Onkologi THT

    36/46

    Juvenile Angiofibroma Nasopharynx

    Histologically benign-Fibrous tissue

    -vascular tissue Unknown etiology Postero-lateral of nasal cavity or superolateral

    of nasopharynx wall. Male, young adult.Hormonal dependent

  • 7/22/2019 Kapita Selekta Onkologi THT

    37/46

    Angifibroma

    Symptoms : -severe epistaxis-progressive nasal obstruction

    Signs : smooth reddish or bluiesh mass in thenasopharynx.

    Investigation:- Should not as a rule be biopsied- CT Scandefine the extent of

    tumor - MRIinvestigation of choice

    to define extent &

    vascularity - Angiographyfeeding

  • 7/22/2019 Kapita Selekta Onkologi THT

    38/46

    Juvenile Angiofibroma Nasopharynx

  • 7/22/2019 Kapita Selekta Onkologi THT

    39/46

    Angiofibroma

    Treatment :-SurgeryTh/ of choice-Poorly radioth/changes tomalignancy.

    -Embolization of feeding artery

    1-2 days pre operatively-Hormonal Th/

    Surgical Approach : - Transpalatal

    - Lateral Rhinotomy- Midfacial degloving-craniofacial approach, if cribriform plate

    involved.

  • 7/22/2019 Kapita Selekta Onkologi THT

    40/46

    Oral cavity cancer

  • 7/22/2019 Kapita Selekta Onkologi THT

    41/46

    Oral cavity cancer

  • 7/22/2019 Kapita Selekta Onkologi THT

    42/46

    Keganasan Lidah (oral tongue cancer)

    Sariawan yg tak sembuh Painless, kecuali bila sudah infiltrasi ke otot lidah Std.diniberupa Leukoplakia, Eritroplakia.

    Paling sering KSS >50%metastasis ke Kgb dalam std awal.

  • 7/22/2019 Kapita Selekta Onkologi THT

    43/46

    Oral tongue cancer

    (worldwide incidence)

  • 7/22/2019 Kapita Selekta Onkologi THT

    44/46

    Oral tongue cancer

  • 7/22/2019 Kapita Selekta Onkologi THT

    45/46

    Keganasan di Telinga & kel.Parotis

  • 7/22/2019 Kapita Selekta Onkologi THT

    46/46